Physician profile
Emily Brown
NPI 1508429952
$647.31
in general payments reported to CMS, 2019-2025
10 companies · $73.45 in 2025
The $73.45 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.45 · 2022: $201 · 2023: $80.78 · 2024: $277 · 2025: $73.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $254.79 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Innocoll Pharmaceuticals Limited | $133.36 | 2022 | |
| Hologic Sales and Service, LLC | $95.96 | 2024 | Trunode, Trident Specimen Radiography System |
| Becton, Dickinson and Company | $55.72 | 2025 | Phasix Mesh |
| Atricure, INC. | $23.42 | 2023 | |
| W. L. Gore & Associates, INC. | $19.72 | 2023 | Gore Excluder Iliac Branch Endoprosthesis |
| Inspire Medical Systems, INC. | $17.73 | 2025 | Inspire |
| Amag Pharmaceuticals, INC. | $15.70 | 2022 | |
| Janssen Biotech, INC. | $15.46 | 2023 | Remicade, Stelara, Simponi Aria |
| Boston Scientific Corporation | $15.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.